Ox-LDL-mediated ILF3 overexpression in gastric cancer progression by activating the PI3K/AKT/mTOR signaling pathway

Background: This study aimed to investigate the relationship of dyslipidemia and interleukin-enhancer binding factor 3 (ILF3) in gastric cancer, and provide insights into the potential application of statins as an agent to prevent and treat gastric cancer. Methods: The expression levels of ILF3 in g...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Danping, Zhang, Mingxiang, Wei, Meng, Wang, Zhaoyang, Qiao, Wen, Liu, Peng, Zhong, Xin, Liang, Yize, Chen, Yuanyuan, Huang, Yadi, Yu, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134943/
https://www.ncbi.nlm.nih.gov/pubmed/35507914
http://dx.doi.org/10.18632/aging.204051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134943/
https://www.ncbi.nlm.nih.gov/pubmed/35507914
http://dx.doi.org/10.18632/aging.204051

Ejemplares similares